Dr. Michael Burnstine Technical Writings
Dr. Michael Burnstine Technical Writings
Peer Reviewed Papers
1. Burnstine MA, Levin LA, Louis DA, Hedley-Whyte WJ, Kupsky EJ, Doepner DD, Albert DM. Nucleolar organizer regions in optic gliomas, Brain, 1993; 116:1465-76.
2. Burnstine MA, Headington JT, Reifler DM, Oestricher JH, Elner VM. Periocular granuloma annulare, nodular type: Occurrence in late middle age, Archives of Ophthalmology, 1994; 112:1590-3.
3. Elner VM, Burnstine MA, Goodman ML, Dortzbach RL. Inverted papillomas that Invade the orbit, Archives of Ophthalmology, 1995; 113:1178-83.
4. Burnstine MA, Frueh BR, Elner VM. Angiosarcoma metastatic to orbit, Archives of Ophthalmology, 1996; 114:93-96.
5. Burnstine MA, Elner VM. Golf-related ocular injuries, American Journal of Ophthalmology, 1996; 121:437-38.
6. Esmaeli B, Burnstine MA, Martonyi CL, Sugar A, Johnson V, Brewer GJ. Regression of Kayser-Fleischer rings during oral zinc therapy: correlation with systemic manifestations of Wilson’s disease, Cornea, 1996; 15:582-86.
7. Strome SW, Hill JS, Burnstine MA, Beck J, Esclamado RM. Anterior ischemic optic neuropathy following neck dissection, Head and Neck, 1997; 19:148-52.
8. Rodman RC, Burnstine MA, Esmaeli B, Sugar A, Martonyi CL, Johnson V, Brewer GJ. Wilson’s disease: presymptomatic patients and Kayser-Fleischer rings, Ophthalmic Genetics, 1997; 18:79-85.
9. Burnstine MA, Elner SG, Elner VM. Interleukin-6 gene expression and inhibition by cytokine-stimulated orbital fibroblasts, ASOPRS thesis, November 1997.
10. Elner VM, Burnstine MA, Strieter RM, Kunkel SL, Elner SG. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in situ hybridization analyses, Experimental Eye Research, 1997; 65:781-89.
11. Elner VM, Burnstine MA, Kunkel SL, Strieter RM, Elner SG. Interleukin-8 and monocyte chemotactic protein-1 gene expression and protein production by human orbital fibroblasts, Ophthalmic Plastic and Reconstructive Surgery, 1998; 14:119-125.
12. Burnstine MA, Elner SG, Elner VM. Orbital fibroblast chemokine modulation: effects of dexamethasone and cyclosporin A, British Journal of Ophthalmology, 1998; 82:318-322.
13. Putterman AM, Burnstine MA. Autogenous fascia lata leg grafts for exposeds cleral buckles, Retina, 1998; 18:283-285.
14. Burnstine MA, Morton AD, Font RL, Boniuk M, Flint A, Meyer KA, Elner VM. Lacrimal gland hemangiopericytoma, Orbit, 1998; 17:189-94.
15. Britt, MT, Burnstine MA. Iopidine allergy causing lower eyelid ectropion progressing to cicatricial entropion, British Journal of Ophthalmology, 1999; 83:992-93.
16. Burnstine MA, Elner SG, Elner VM. Interleukin-6 gene expression and inhibition by cytokine-stimulated orbital fibroblasts, Ophthalmic Plastic and Reconstructive Surgery, 1999; 15:306-311.
17. Burnstine MA, Putterman AM. Upper blepharoplasty: a novel approach to progressive myopathic blepharoptosis, Ophthalmology, 1999; 106:2098-2100.
18. Burnstine MA, Sugar J, Putterman AM. Cicatricial entropion caused by asymptomatic allergic conjunctivitis, Orbit, 1999; 16: 211-216.
19. Burnstine MA, Discussion of primary implant placement with evisceration in patients with endophthalmitis. Ophthalmology, 2000; 107; 1664-65.
20. Adjemian A, Burnstine MA. Lacrimal canalicular diverticulum, a cause of epiphora and discharge, Ophthalmic Plastic Reconstructive Surgery, 2000; 16; 471-2.
21. Read RW, Burnstine MA, Rowland JM, Zamir E, Rao NA. Rhabdomyomatous mesenchymal hamartoma of the eyelid: report of a case and literature review. Ophthalmology, 2001; 108: 798-804.
22. Saks ND, Burnstine MA, Putterman AM. Glabellar rhytids in thyroid-associated orbitopathy, Ophthalmic Plastic and Reconstructive Surgery, 2001; 17: 91-95.
23. Nazemi PP, Chong LP, Varma R, Burnstine MA. Migration of silicone oil into the subconjunctival space and orbit through an Ahmed glaucoma valve, American Journal of Ophthalmology, 2001; 132: 929-931.
24. Burnstine MA. Indications and timing for repair of isolated orbital floor fractures: an evidence-based analysis, Ophthalmology, 2002; 109: 1207-1213.
25. Zamir E, Smith RE, See RF, Yiu SC, Burnstine MA, Rao NA. Squamous cell carcinoma of the limbus extending into the anterior segment. Archives of Ophthalmology, 2002; 120: 1106-1107.
26. Agarwal MR, Esmaeli B, Burnstine MA. Squamous metaplasia of the canaliculi secondary to 5-fluorouracil: a clinicopathologic case report, Ophthalmology, 2002; 109: 2359-2361.
Articles In Press
Articles Submitted
1. Esmaeli B, Burnstine MA, Ahmadi A, Prieto VG. Docetal- induced histologic changes in the lacrimal sac and nasal mucosa, Archives of Ophthalmology.
2. Dresner SC, Uzcategui N, Burnstine MA. Orbitotemporoneurofibromitis: classification and treatment, Ophthalmic Plastic and Reconstructive Surgery.
Articles In Preparation
1. Krantz KB, Nguyen R, Quiros P, Burnstine MA, Sinha UK, Rao NA. Sebaceous cell carcinoma: natural history of a neglected tumor.
2. Burnstine MA, Putterman AM, Valvassori GE, Mafee MF. Extraocular muscle fatty infiltration: a new finding in thyroid-associated orbitopathy.
Non-Peer Review
1. Charters L, Kaplan L, Burnstine MA. Erbium, C02 lasers play big role in oculoplastics field. Ophthalmology Times, 1998; 23:24:12,26.
2. Charters L, Burnstine MA. Upper blepharoplasty an alternative for ptosis in CPEO. Ophthalmology Times, 1999; 24:1;36.
3. Burnstine MA, Putterman AM. Bobbypin ptosis procedure not “new”. Ophthalmology Times, 1999; 24:8;4.
Abstracts
1. N. Liu – ASCRS abstract – Boston 1999-
2. Sanjay Rao – ASCRS
Book Reviews
1. Burnstine MA. Cosmetic Oculoplastic Surgery: Eyelid, forehead and facial techniques, Archives of Ophthalmology, 1999; 117:1100-01.
2. Burnstine MA. Oculoplastic Surgery, the Requisites by Jeffrey A. Nerad. Archives of Ophthalmology, 2002; 120: 1603.
Letters to the editors
1. Putterman AM, Burnstine MA. Reversal of iatrogenic punctal and cannalicular occlusion, Ophthalmology, 1997; 104:901-02.
2. Burnstine MA. Minimal endoscopic approach, Arch Otolaryngol Head Neck Surgery, 1998; 124:711.
3. Burnstine MA, Putterman AM. Myogenic ptosis, Ophthalmology, submitted.
Chapters
1. Putterman AM, Burnstine MA. Lower blepharoplasty: transconjunctival approach. In: Facial Plastic and Reconstructive Surgery. Ed. Toriumi D. Lippincott-Raven, Philadelphia, PA, 2002.
2. Burnstine MA, Putterman AM. Midface Lift. In: Facial Plastic and Reconstructive Surgery. Ed. Toriumi D. Lippincott-Raven, Philadelphia, PA, 2002.
3. Burnstine MA. The Ocular Adnexa – Eyelids: Ectropion. In: Corneal and Extrenal Diseases. Ed. O’Brien T, McDonnel PJ, Thieme Medical Publishers, Inc., New York, New York, (submitted).
4. Burnstine MA, Putterman AM. Upper blepharoplasty: a novel approach to progressive myopathic blepharoptosis. Advances in Plastic Surgery, (in press)
Posters
1. Burnstine MA, Levine LA, Louis DA, Hedley-Whyte ET, Kupsky WJ, Doepner DD, Albert DM. Nucleolar organizer regions in optic gliomas, Association for Research in Vision and Ophthalmology (ARVO), Sarasota, Florida, May 1992.
2. Esmaeli B, Burnstine MA, Brewer GJ, Martonyi CL. Disappearance of Kayser Fleischer rings in response to anti-copper therapy in patients with Wilson’s Disease, American Academy of Ophthalmology, San Francisco, California, November 1994.
3. Rodman, RC, Burnstine MA, Esmaeli B, Sugar A, Martonyi CL, Johnson V, Brewer GJ. Wilson’s disease: presymptomatic patients and Kayser-Fleischer rings, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, Florida, April 1996.
4. Dresner SC, Uzcategui N, Burnstine MA. Orbitotemporal neurofibromatosis: classification and treatment. American Society ofOphthalmic Plastic and Reconstructive Surgery (ASOPRS), Orlando, Florida, October,2002.
Presentations
Local
1. Burnstine MA, Inverted papillomas that invade the orbit, Scientific Program, University of Michigan, June 1994.
2. Burnstine MA. Regression of Kayser-Fleischer rings during oral zinc therapy: correlation with systemic manifestations of Wilson’s disease, Scientific Program, University of Michigan, June 1995.
3. Burnstine MA. Interleukin-8, monocyte chemotatic protein-1, and orbital fibroblasts: a possible role in orbital inflammation, Scientific Program, University of Michigan, June 1996.
4. Burnstine MA. Autogenous fascia lata leg grafts for exposed scleral buckles, Scientific Program, University of Illinois at Chicago – Eye and Ear Infirmary, June 1997.
5. Burnstine MA. CT and MRI of the eye and orbit, CME, Doheny Eye Institute, University of Southern California, November 8, 1997.
6. Burnstine MA. Update in orbit: exam and orbital trauma, CME, Doheny Eye Institute, University of Southern California, March 14, 1998.
7. Burnstine MA. Upper blepharoplasty: a novel approach to progressive external ophthalmoplegia, CME, Doheny Days, University of Southern California, June 13, 1998.
8. Burnstine MA. Eyelid reconstruction, ENT Grand Rounds, Los Angeles County and USC Medical Center, Los Angeles, California, August 8, 1998.
9. Burnstine MA, The socket, CME, Doheny Eye Institute, University of Southern California, March 13, 1999.
10. Burnstine MA. Glabellar rhytids in thyroid-associated orbitopathy, CME, Doheny Days, University of Southern California, June 11, 1999.
11. Burnstine MA. Indications and timing for repair of isolated orbital floor fractures: an evidence-based analysis, Doheny Days, University of Southern California, June 10, 2000.
12. Burnstine MA. Ocular Aesthetics, CME, Doheny Eye Institute, University of Southern California (Course Director and lecturer on “A Rational Approach to the Aging Face”), October 14, 2000.
13. Burnstine MA. Transconjunctival lower blepharoplasty. 70th Annual Midwinter Ophthalmology Conference. Research Study Club of Los Angeles, Los Angeles, CA, January 27, 2001.
14. Burnstine MA. Temporoorbital Neurofibromatosis: diagnosis and management; Doheny Days, University of Southern California, June 15, 2001.
15. Burnstine MA. “The Aging Face”. Chapman Medical Center, Orange, CA, July 12, 2001.
16. Burnstine MA. Ectropion: diagnosis and management. California Academy of Ophthalmology, Santa Monica, CA, September 15, 2001.
17. Burnstine MA. The Aging Face. San Diego County Eye Society, San Diego, CA, October 15, 2001.
18. Burnstine MA. Autogenous fascia lata leg grafts for exposed scleral buckles, Doheny Days, University of Southern California, June 8, 2002.
19. Burnstine MA. Blepharoplasty of the lower lid with finesse, Ocular Aesthetics CME Course, Doheny Eye Institute, University of Southern California, November 9, 2002.
National/International
1. Elner VM, Burnstine MA, Goodman ML, Dortzbach RL. Inverted papillomas that Invade the orbit, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), San Francisco, California, October 1994.
2. Burnstine MA. Orbital fibroblast interleukin-6 gene expression and immunomodulation, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), San Francisco, California, October 25, 1997.
3. Saks N, Burnstine MA, Putterman AM. A new clinical finding in thyroid-associated orbitopathy: glabeller furrows, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), New Orleans, Louisiana, November 7, 1998.
4. Burnstine MA, Putterman AM. Upper blepharoplasty: a novel approach to progressive external ophthalmoplegia, American Academy of Ophthalmology (AAO), New Orleans, Louisiana, November 10, 1998.
5. Burnstine MA. Cases of lower eyelid avulsion and assymetric margin fold distances after upper blepharoplasty, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) Spring Meeting, Phoenix, Arizona, May 19, 1999.
6. Burnstine MA, Liu N, Smith RE, Chuck R Amniotic membrane transplantation: the Doheny Eye Institute experience. European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS), Istanbul, Turkey, September 16, 1999.
7. Burnstine MA, Olson, JJ. Cicatricial entropion treated by amniotic membrane spacer graft placement. American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), Orlando, Florida, October 23, 1999.
8. Burnstine MA, Putterman AM. Upper blepharoplasty: a novel approach to improving progressive myopathic blepharoptosis. Pan American Association of Ophthalmology/American Academy of Ophthalmology, Orlando, Florida, October 24, 1999.
9. Burnstine MA, Discussion of paper by Steven Dresner: Primary implant placement with evisceration in patients with endophthalmitis. American Academy of Ophthalmology, Orlando, Florida, October 26, 1999.
10. Burnstine MA. Eyelid Reconstruction after inadvertant levator excision during blepharoplasty. American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) Spring Meeting, Hot Springs, VA, June 20, 2000.
11. Burnstine MA. Indications and timing for repair of isolated orbital floor fractures: an evidence-based analysis, European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS), Paris, France, September 15, 2000.
12. Burnstine MA. Indications and timing for repair of isolated orbital floor fractures: an evidence – based analysis. American Academy of Ophthalmology (AAO), Dallas, TX, October 25, 2000.
13. Dresner SC, Uzcategui N, Burnstine MA. MRDf and MRDp: two new measurements for evaluating upper eyelid malpositions, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), Orlando, FL, October 19, 2002.
American Academy of Ophthalmology Courses
1. Tanenbaum M, Holds JB, Burnstine MA, Mazzoli RA, Maus M. Ask the Experts. American Academy of Ophthalmology, San Francisco, California, October 26-29, 1997.
2. Mercandetti M, Mirante JP, Munier M, Weiss RA, Klett ZG, Silbert D, Reino AJ, Farrior E, Burnstine MA, Brown MS, Milite JP, Cole EA. Dacryoplasty, balloon catheter DCR and powered instrumentation endoscopic DCR’s, American Academy of Ophthalmology (AAO), Orlando, Florida, October 27, 1999.
3. Mercandetti M, Mirante JP, Munier M, Weiss RA, Klett ZG, Silbert D, Reino AJ, Farrior E, Burnstine MA, Brown MS, Milite JP, Cole EA. Dacryoplasty, balloon catheter DCR and powered intstrumentation endoscopic DCR’s, American Academy of Ophthalmology (AAO), Dallas, Texas, October 24, 2000.
4. Burnstine MA. Periocular reconstruction. American Academy of Ophthalmology (AAO), New Orleans, Louisiana, November 13, 2001.
5. Mercandetti M, Mirante JP, Munier M, Weiss RA, Klett ZG, Silbert D, Duffy MT, Cohen AJ, Belrado JP, Burnstine MA, Brown MS, Milite JP, Cole EA. Dacryoplasty, balloon catheter DCR and powered instrumentation endoscopic DCR’s, American Academy of Ophthalmology, (AAO), New Orleans, Louisiana, November 13, 2001.
6. Burnstine MA. Ask the experts. American Society of Ophthalmic Plastic and Reconstructive Surgery, American Academy of Ophthalmology (AAO), New Orleans, Louisiana, November 12, 2001.
7. Esmaeli B, Yeatts RP, Burnstine MA, Mazzoli RA, Schaefer DP. Diagnosis and management of periocular and conjunctival malignancies. American Academy of Ophthalmology (AAO), October 20, 2002.
8. Mercandetti M, Mirante JP, Silbert D, Weiss RA, Belarado JP, Javate RM, Burnstine MA, Duffy MT, Brown MS, Klett ZG, Munier M, Cohen AJ. Dacryoplasty, Balloon catheter DCR and powered instrumentation endoscopic DCR’s, American Academy of Ophthalmology, (AAO), New Orleans, Louisiana, October 21, 2002.